Promise Ledger
Every outstanding corporate promise with a resolution deadline — and the ones that just resolved. Descriptive, sourced, receipt-backed.
No quarterly guidance · 7
A company that gave quarterly guidance at least six quarters in a row, then gave none for a quarter. Each entry is checked against the company's earnings release.- BAXFull-year guidance only: no quarterly guidance for Q1 of fiscal 2026, after at least 20 quarters with itFilingJun 30, 2026
- FTVFull-year guidance only: no quarterly guidance for Q3 of fiscal 2025, after at least 18 quarters with itFilingDec 30, 2025
- TGTFull-year guidance only: no quarterly guidance for Q1 of fiscal 2025, after at least 8 quarters with itFilingJun 30, 2025
- AVGOFull-year guidance only: no quarterly guidance for Q1 of fiscal 2024, after at least 14 quarters with itFilingJun 30, 2024
- DFull-year guidance only: no quarterly guidance for Q1 of fiscal 2024, after at least 14 quarters with itFilingJun 30, 2024
- IQVFull-year guidance only: no quarterly guidance for Q1 of fiscal 2023, after at least 12 quarters with itFilingJun 30, 2023
- RVTYFull-year guidance only: no quarterly guidance for Q1 of fiscal 2023, after at least 12 quarters with itFilingJun 30, 2023
Dividend activity · 300
Declared dividends, shown as history — descriptive, not scored, no verdict.Streaks & reversals
A company's recent run of kept promises, and runs that just reversed — descriptive, backward-looking.On a streak · 27
274 open · Buyback
- FDXBuybackThe company expects to repurchase an additional $500 million of common stock during fiscal 2025resolves in ~51 days
- SLBBuybackSLB entered into ASR transactions to repurchase $2.3 billion of its common stockresolves in ~80 days
- NFLXBuybackOur Board has approved an incremental $15B for the program which brings our total buyback authorization to $17.1Bresolves in ~84 days
- UNPBuybackShare repurchases of $4.0 to $4.5 billionresolves in ~86 days
- HCABuybackThe HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase program for up to $10 billion of the Company’s outstanding common stock.resolves in ~87 days
- AREBuybackauthorized a common stock repurchase program under which we may repurchase up to $500.0 millionresolves in ~90 days
- TMUSBuybackThe current authorization allows for stock repurchases and dividends through December 2025 of up to $14.0 billionresolves in ~92 days
- HSICBuybackthe Company’s Board of Directors has authorized an increase of $500 million to the Company’s stock repurchase programresolves in ~92 days
- CIBuybackbringing the company's total share repurchase authority to $10.3 billionresolves in ~93 days
- PHMBuybackthe Company announced that its Board of Directors approved a $1.5 billion increase to the Company’s share repurchase authorizationresolves in ~93 days
- AONBuybackreturning capital to shareholders, including $1 billion in share repurchasesresolves in ~94 days
- GWWBuybackShare Buyback $1.15 - $1.25 billionresolves in ~94 days
- IDXXBuybackOutlook assumes ~$1.5 billion of share repurchases in 2025resolves in ~97 days
- MTCHBuybackauthorized a new repurchase program of up to $1.5 billionresolves in ~98 days
- BDXBuybackthe repurchase of up to 10 million shares of BD common stockresolves in ~99 days
- EMRBuybackapproximately $2.0 billion of share repurchasesresolves in ~99 days
- SWKSBuybackapproved a new $2 billion stock repurchase programresolves in ~99 days
- PTCBuybackWe currently intend to repurchase approximately $300 million of our common stock in FY’25resolves in ~99 days
- ITWBuybackthe company plans to repurchase approximately $1.5 billion of its own sharesresolves in ~99 days
- ICEBuybackExpect to resume share repurchases in the first quarterresolves in ~100 days
- DASHBuybackauthorized the repurchase of up to $5.0 billion of our Class A common stockresolves in ~105 days
- CSCOBuybackCisco’s board of directors has also approved a $15 billion increase to the authorization of the stock repurchase programresolves in ~106 days
- ADIBuybackthe Board of Directors authorized the company to repurchase an additional $10.0 billion of its common stockresolves in ~113 days
- CFBuybackIntend to repurchase remaining $1.1B of authorization by December 2025 expirationresolves in ~113 days
- TRMBBuybackThe Board of Directors has authorized a common stock repurchase authorization of up to $1 billionresolves in ~113 days